iguratimod has been researched along with Recrudescence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, W; Chen, D; Chen, J; Fu, J; Li, Y; Li, Z; Liu, Y; Sun, X; Zhang, W; Zhang, Y; Zhao, X | 1 |
| Fujimoto-Hirakawa, Y; Fukuda, W; Iwai, T; Kobayashi, T; Kuriyama, K; Kuroda, J; Matsumoto, Y; Mizutani, S; Nagata, H; Nishikawa, R; Ohshiro, M; Shimura, Y; Tsukamoto, T; Uchiyama, H; Yamamoto-Sugitani, M | 1 |
2 other study(ies) available for iguratimod and Recrudescence
| Article | Year |
|---|---|
Efficacy and safety of iguratimod on patients with relapsed or refractory IgG4-related disease.
Topics: Adult; Aged; Chromones; Cyclophosphamide; Female; Glucocorticoids; Humans; Immunoglobulin G; Immunoglobulin G4-Related Disease; Immunosuppressive Agents; Lacrimal Apparatus; Leflunomide; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisone; Recurrence; Retrospective Studies; Salivary Glands; Sulfonamides; Treatment Outcome; Young Adult | 2020 |
Iguratimod triggers the relapse of methotrexate-associated lymphoproliferative disorder.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Chromones; Female; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Methotrexate; Recurrence; Sulfonamides | 2021 |